Novoheart Opens New State-Of-The-Art Facilities at the Hong Kong Science Park

Novoheart is pleased to announce the opening of its brand new Hong Kong facility consisting of 5,300 ft² of integrated laboratory and office space. Located in the Hong Kong Science Park, the laboratory is equipped with state-of-the-art facilities for stem cell production, tissue engineering and world-class research and development. The facility provides Novoheart with a new level of scalability enabling it to accommodate a significant number of additional revenue-generating commercial contracts and projects.

With the newly expanded Hong Kong facilities, operations are being streamlined to ensure its growing R&D team works seamlessly with those located in Irvine, California location, and the two locations enable R&D programs to operate continuously round the clock. In addition to this facility being an advantage for global clients, Novoheart will continue to deliver best-in-class drug discovery tools for pharmaceutical and biotech clients.

For the detailed press release, please click here.

Subscribe To Our Newsletter

Fill out the following to subscribe and start receiving updates from us!